Key result
Reminder cards improve 3-month medication compliance by ~10% versus control.
Why the study?
Do reminder cards improve medication compliance and blood pressure control in patients taking once-daily ACEI monotherapy?
Do reminder cards improve medication compliance and blood pressure control in patients taking once-daily ACEI monotherapy?
Absolute Event Rate: 97.3% vs 87.3%
p-value: p=0.011
Reminder cards may improve medication compliance in patients taking antihypertensive therapy, though larger studies are needed to confirm clinical benefits such as blood pressure reduction.
Reminder cards may improve antihypertensive adherence in community pharmacies; leaves open effects on BP control or outcomes.
Objective Poor compliance to antihypertensive medications has been identified as a primary cause of uncontrolled blood pressure (BP), with consequent increases in hypertension-related morbidity and mortality. Therefore, any measure known to improve compliance should be encouraged. This study assessed the impact of reminder cards on compliance to antihypertensive therapy. Method A field trial was undertaken in pharmacies located in the districts of Lisbon and Porto. Eligible participants comprised those aged 30–74 years, prescribed an angiotensin-converting enzyme inhibitor (ACEI) in monotherapy, and taken on a once-daily regimen. Patients were allocated to control group (CG) or intervention group (IG), the latter being provided with a reminder card, an alarm-type device due to remind the patient of the time to take his medication. Patients were monitored monthly during 3 months for compliance and blood pressure control. Key findings Seventy-one patients participated in the study (intervention: 35; control group: 36). Compliance was similar between the groups in the first 2 months of follow-up (97.1% IG vs 94.9% CG at first follow-up and 97.5% IG vs 94.2% CG at second follow-up) and higher in the intervention group at the end of the study (97.3% IG vs 87.3% CG; P = 0.011). There were no mean blood pressure differences between compliant and non-compliant subjects at the end of the study (P value for differences in systolic BP (Psyst) = 0.580; and P value for differences in diastolic BP (Pdlast) = 0.175). Conclusion This small-scale study indicates a possible positive impact on patients' compliance resulting from the use of reminder cards. However, this needs confirming in larger scale studies with longer monitoring periods.
No takes yet. Share an insight, caveat, or question.
Costa et al. (2005) studied Hypertension (n=71). Reminder cards vs. Control group was evaluated on Compliance at the end of the study (p=0.011). The use of reminder cards significantly improved medication compliance compared to control at 3 months (97.3% vs 87.3%; P=0.011).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: